# Abiraterone Acetate Trial in African American Prostate Cancer Patients

> **NCT01735396** · PHASE2 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 11 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Abiraterone Acetate

## Key facts

- **NCT ID:** NCT01735396
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** poor accrual
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735396, "Abiraterone Acetate Trial in African American Prostate Cancer Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01735396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*